A Phase 1 study of tocilizumab-aazg in aneurysmal subarachnoid hemorrhage
Recruiting Phase 1 NCT06863480
Study Description
Evaluating the safety and potential stroke prevention effects of tocilizumab-aazg in patients with a ruptured brain aneurysm
Study Details
- Registry ID:
- NCT06863480
- Conditions:
- Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia
- Phase:
- Phase 1
- Target Enrollment:
- 30 participants
- Start Date:
- Age Range:
- 18–89 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
University of Florida Health (UF Health)
Gainesville, Florida, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.